§ Mr. Gordon PrenticeTo ask the Secretary of State for Health what the expenditure per capita was on pharmaceuticals in each of the OECD countries for the most recent year for which figures are available. [11893]
§ Ms BlearsExpenditure per capita on pharmaceuticals and other medical non-durables in each of the OECD countries for the most recent year for which figures are available is shown in the table.
£ Country Last available year Expenditure per capita Australia 1998 118 Austria n/a n/a Belgium 1997 203 Canada 2000 212 Czech Republic 1999 64 Denmark 1999 155 Finland 1999 160 France 1999 323 Germany 1998 206 Greece 2000 108 Hungary 1999 56 Iceland 1999 258 Ireland 1999 105 Italy 1997 179 Japan 1998 226 Korea 1999 42 Luxembourg 1999 198 Mexico n/a n/a Netherlands 1999 149 New Zealand 1997 115 Norway 1997 157 Poland n/a n/a Portugal 1998 133 Slovakia n/a n/a Spain 1997 126 Sweden 1997 172 Switzerland 1998 176 United Kingdom 1997 149 Turkey 1994 16 United States 1999 296 n/a = Not available Notes:
1. The table displays figures for the "total expenditure on pharmaceuticals and other medical non-durables", comprising "pharmaceuticals such as medicinal preparations, branded and generic medicines, drugs, patent medicines, serums, vaccines, vitamins and minerals and oral contraceptives plus a wide range of medical non-durables such as bandages, elasticated stockings, incontinence articles, condoms and other mechanical contraceptive devices".
474W2. The data have been converted from US$ terms into UK£ terms using the exchange rate series published in the same OECD database.
Source:
Figures are taken from OECD Health Data 2001